Effects of Cohort Selection on the Results of Cost-Effectiveness Analysis of Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis

BACKGROUND: Decision-analytic cost-effectiveness models are used to determine the most cost-effective treatment option on the basis of the best available data. Guidelines for pharmacoeconomic model development indicate that models should be updated as new evidence becomes available. OBJECTIVES: To e...

Descripción completa

Detalles Bibliográficos
Autores principales: Becker III, Russell V., Dembek, Carole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2011
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438299/
https://www.ncbi.nlm.nih.gov/pubmed/21657808
http://dx.doi.org/10.18553/jmcp.2011.17.5.377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438299/
https://www.ncbi.nlm.nih.gov/pubmed/21657808
http://dx.doi.org/10.18553/jmcp.2011.17.5.377

Ejemplares similares